The TORCH screen and intrauterine infections TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes) screening has become almost synonymous with the investigation of an unexpected small for dates and/or premature infant with or without other abnormalities, and of apparently unknown cause. If no further direction is given to the house officer, he or she will embark on a series of unnecessary tests and may compound the error by sending inappropriate samples. The futility of such an approach has already been highlighted in a recent editorial.' The aim of this annotation is to further hasten the demise of the 'TORCH screen' by considering three specific areas. Firstly, to consider the presentation of congenital infections and to stress that there are now more congenital infections than were originally encompassed by the term TORCH. Rather than expand the screening test clinicians should be aware that many infections present with specific clinical pictures and they should direct investigations accordingly. Secondly, to emphasise the rarity of any congenital infection and thus the poor yield of the blunderbuss approach of the TORCH screen. Thirdly, to consider whether antenatal diagnosis will reduce or even eliminate the need for neonatal TORCH screening.
(1) Postnatal presentation
To request a TORCH screen on a neonate suggests that certain abnormalities are characteristic of congenital infection and the clinical presentation of different agents is similar. Neither supposition is watertight. For example, although growth retardation can occur in congenital herpes2 or syphilis, 50 infants with cytomegalovirus infection had weights and head circumferences that did not differ significantly from those of 97 controls.3 In addition, HIV infection, except in babies of seropositive mothers from Zaire,4 has not been associated with growth retardation.5 Prematurity is not a sine qua non of congenital infection, although typical of congenital syphilis, it is not increased by cytomegalovirus infection. Investigation of a small for dates or premature infant is extremely unlikely to identify any of the congenital infections. Only 10 to 15% of infants infected by toxoplasmosis during pregnancy have abnormalities in the neonatal period,6 even though 50% develop neurological sequelae or chorioretinitis by the age of 20 years.7 Parvovirus infection is associated with nonimmune hydrops, but rarely causes congenital malformation,8 indeed there is only one report of a fetal eye anomaly.9
Clinical signs that are presumed to be a non-specific clue to congenital infection may, in fact, be characteristic of one particular agent. Syphilis presents with many of the signs expected from a TORCH infection, a vesicular and erythematous skin rash, petechiae, severe non-haemolytic anaemia, and hepatosplenomegaly. In addition, the infant may suffer intestinal malfunction due to syphilitic enterocolitis, respiratory distress because of prematurity and/or pneumonia alba. The associated condylomata are, however, specific as are, in 95% of infants with congenital syphilis, the characteristic long bone changes (symmetrical metaphyseal lesions, horizontal bands of increased/ decreased radiodensity, and peripheral porosis.10 The diagnosis will be further advertised by the peeling of the soles of the feet and palms of the hands and can be confirmed by isolation of the spirochaete from the vesicular lesions. Reliance on the clinical signs described by the TORCH syndrome to identify congenitally infected infants could result in underdiagnosis of other including more recently described infections. Infants with listeriosis may present solely with septicaemia or an unusual pneumoniall and this infection should be considered in the differential diagnosis of any infant presenting with septicaemia and/or pneumonia, particularly if premature labour has been complicated by meconium stained liquor. natal illness, only 5% of the 1800 children born alive each year in England and Wales congenitally infected with cytomegalovirus will develop cytomegalic inclusion disease and a further 5% serious handicaps later.14 In the USA, although cytomegalovirus is the commonest congenital infection affecting 30 000 to 40 000 liveborn infants annually, only 1500 to 4000 per year are severely damaged.
It is important, however, to be aware of the variation between countries in the incidence of certain types of infection. In the UK, congenital toxoplasmosis occurs in between 1 to 2 per 1000 live births, but in other countries affects as many as 3 to 6 per 1000 births. 15 The latter figure has influenced countries such as France and Austria to hold national antenatal screening programmes. Only 36 neonatal herpes infections were reported in the two year period 1987-8, giving a rate of 1 in 33 000 births in the UK16 but, in the USA, the rate recently increased to one in 5000. apparent even at birth. In listeriosis, the presentation is nonspecific, reduction in fetal movements and a poor biophysical profile score. 25 Maternal symptomatology is not a good guide to prognosis and, therefore, the need for screening. Symptomatic or asymptomatic rubella acquired in the first four months of pregnancy results in the same morbidity. 26 Congenitally acquired disease can follow asymptomatic maternal infection.27 It should also be remembered that a history of previous rubella infection or immunisation cannot, with certainty, exclude the possibility of an infected fetus as reinfection and vaccination failure do occur.
(B) HIGH RISK GROUPS High risk groups for certain infections can be identified but, for HIV and hepatitis B infection, this involves large numbers. Prostitutes, intravenous drug abusers, the sexual partners of bisexual men, or those who have received blood clotting factors are all at increased risk of HIV infection. The screening net must be widened for hepatitis B virus to include not only the groups described above but also mothers with a recent history of jaundice,28 white people from southern and eastern Europe, and ethnic groups other than white people from outside Europe. Although women at high risk from cytomegalovirus infection are those that are non-immune, as this amounts to 50% of women of childbearing age,29 screening for such patients is not a realistic method of eliminating the need for one component of the neonatal TORCH screen. Accurate antenatal tests are highly desirable but, unfortunately, toxoplasmosis IgM has a poor specificity to detect women actively infected, 20% of whom after 20 weeks of gestation will transmit the infection to their fetus. The IgM is not necessarily indicative of recent infection and can persist for years, as a consequence further investigation is only required of mothers who seroconvert during pregnancy or have an initially high antibody titre. This has involved isolation of the parasite by means of mouse inoculation and results may not be available for four or five weeks. The combination of amniocentesis and placenta culture from transabdominal chorion villus sampling (which has a positive predictive value of 90%) may reduce the waiting period to five days, but the case so far reported30 had overwhelmingly fatal infection. 
